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Abstract
With the continuing evolution of pharmacy as a clinical profession, the need to prepare well-trained clinicians
beyond the knowledge gained from a doctor of pharmacy degree program is magnified. Such training is
afforded by pharmacy residency programs, which have expanded from hospital sites to practice settings as
diverse as managed care organizations and public health departments. Although the resident benefits from the
intensive training program, the sponsoring institution also derives many benefits from hosting the residency.
Fundamentally, residents are licensed pharmacists who provide several contributions to the organization at
generally a much-reduced direct cost. Federal funding for graduate medical education, often referred to as
Medicare pass-through funds, is a common source of support for the conduct of postgraduate year one
residency programs in health system settings; other sources of funding may be found in organizational and
academic outlets. Residents may be integral in expanding the revenue of an organization by serving as patient
care providers, developing or enhancing services, and billing for services delivered. By virtue of the roles they
can assume, residents can facilitate the redeployment of existing pharmacists to other areas, tasks, or projects,
thus expanding the capabilities of the department. Increasing the capacity to conduct experiential education
for pharmacy students, and the compensation for such activity, can be an additional benefit. Practice sites that
conduct residency training often experience a greater degree of employee satisfaction and higher employee
retention rates. Engaging in quality improvement and assessment activities, assisting in staff development, and
supporting innovative approaches to care are additional activities that pharmacy residents can support. This
primer from the American College of Clinical Pharmacy was developed to highlight the value an organization
can realize by conducting pharmacy residency training.
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A C C P W H I T E P A P E R
Value of Conducting Pharmacy Residency Training—
The Organizational Perspective
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Paul P. Dobesh, Pharm.D., James D. Hoehns, Pharm.D., Kristine B. Marcus, B.S.,
Steven E. Pass, Pharm.D., Amy L. Seybert, Pharm.D., and Nancy L. Shapiro, Pharm.D.
With the continuing evolution of pharmacy as a clinical profession, the need
to prepare well-trained clinicians beyond the knowledge gained from a doctor
of pharmacy degree program is magnified. Such training is afforded by
pharmacy residency programs, which have expanded from hospital sites to
practice settings as diverse as managed care organizations and public health
departments. Although the resident benefits from the intensive training
program, the sponsoring institution also derives many benefits from hosting
the residency. Fundamentally, residents are licensed pharmacists who
provide several contributions to the organization at generally a much-reduced
direct cost. Federal funding for graduate medical education, often referred to
as Medicare pass-through funds, is a common source of support for the
conduct of postgraduate year one residency programs in health system
settings; other sources of funding may be found in organizational and
academic outlets. Residents may be integral in expanding the revenue of an
organization by serving as patient care providers, developing or enhancing
services, and billing for services delivered. By virtue of the roles they can
assume, residents can facilitate the redeployment of existing pharmacists to
other areas, tasks, or projects, thus expanding the capabilities of the
department. Increasing the capacity to conduct experiential education for
pharmacy students, and the compensation for such activity, can be an
additional benefit. Practice sites that conduct residency training often
experience a greater degree of employee satisfaction and higher employee
retention rates. Engaging in quality improvement and assessment activities,
assisting in staff development, and supporting innovative approaches to care
are additional activities that pharmacy residents can support. This primer
from the American College of Clinical Pharmacy was developed to highlight
the value an organization can realize by conducting pharmacy residency
training.
Key Words: pharmacy residency, residency value, residency capacity,
justifying residency training, clinical pharmacy.
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Pharmacy residencies emanated from advanced
training programs in university hospitals, most
notably hospital internships that began in the
1930s. The development of such residency
programs led to the establishment of an
accreditation process for pharmacy residencies in
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1962, administered by the American Society of
Health-System Pharmacists (ASHP). Four years
later, residency training in community settings
was stimulated by the launch of the Community
Pharmacy Residency Program by the American
Pharmacists Association (APhA). Contemporary
training models continue to support the delivery
of such postgraduate training, but in a host of
additional practice settings (e.g., health
departments, managed care organizations,
physician office practices). Even though the
number of ASHP-accredited programs surpassed
1000 and the number of residency positions
exceeded 2000 in 2009, it has been posited that
this current scope of residency training is
insufficient to prepare pharmacists to meet the
needs of medication use systems in the evolving
U.S. health system. The American College of
Clinical Pharmacy (ACCP) asserts that formal
postgraduate pharmacy residency training should
be required for a pharmacist to enter direct patient
care practice by 2020.1 Similarly, ASHP has
described a vision in which 90% of new
pharmacists entering hospital and health system
practice will have completed an ASHP-accredited
residency by 2015.2 Increasing the profession’s
capacity to prepare pharmacists through residency
training is critical to achieving this vision.
Expansion in pharmacy residency training
capacity can occur through both the
development of new programs and the growth of
existing programs. Given the economies of scale
and the benefit of experience gained from
conducting training, ACCP encourages existing
program directors to increase the number of
residency positions to maximize their training
capacity.
Organizations that conduct residency training
are committed to the value it brings to each
resident; however, their commitment to
providing this education is not entirely altruistic.
There must also be a value realized by the
organization to engage in this work.
Administrators may find the costs (e.g., salary,
fringe benefits, travel, accreditation, preceptor
time and training) incurred in the conduct of
residency training daunting, but when the overall
value proposition of residency training to the
organization is analyzed, the perspective may
shift substantially. Residents are licensed
pharmacists who represent the potential to
facilitate capacity building in virtually any
departmental or organizational effort, and they
generally do so at a dramatically reduced direct
cost to the organization.
The 2008 ACCP Task Force on Residencies
was convened to cull the professional literature
and the residency-training environment and
assemble a document to assist administrators in
justifying the expansion of existing—or the
development of new—pharmacy residency
programs. Points of justification are presented as
value realized by the organization, including
external funding sources; expanded revenue
opportunities; staff recruitment, development,
and satisfaction; capacity building for the
delivery of education and scholarship; and
support of innovation (Figure 1).
External Funding
Funds to support the conduct of pharmacy
residency training are available at the federal,
state, and local levels, and several of the
opportunities available for this support are
described.
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Figure 1. Value from pharmacy residency training.
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Federal Funding
In addition to providing payment to hospitals
for care received by Medicare beneficiaries, the
Centers for Medicare and Medicaid Services
(CMS) provides payments to hospitals to support
graduate medical education (GME). Commonly
referred to as Medicare “pass-through” funds,3
these payments generally support physician
postgraduate training in medical residency
programs, with some funds allocated for other
health professionals, including pharmacy
residents. These funds, which compensate
providers (e.g., hospitals) for costs incurred from
approved educational activities, fall into two
categories for which different payment policies
apply.4 The first category represents payments
CMS makes to hospitals for residents who are
training in medicine, dentistry, osteopathy, and
podiatry. The second category includes approved
“nursing and allied health education programs”
operated by the provider (e.g., pharmacy
residency programs). The costs of these
programs are excluded from the definition of
inpatient hospital operating costs, as well as the
calculation of payment rates for hospitals
reimbursed under the prospective payment
system that are subject to the “rate-of-increase”
ceiling. These costs, identified separately, are
“passed through” (that is, paid separately on a
reasonable cost basis). On a practical level, it is
favorable to GME reimbursement for a pharmacy
residency to be included in this second category
because it is not subject to the limits in
reimbursement that affect programs in the first
category.
Certain requirements must be met for a
pharmacy residency program to be eligible for
GME funds from CMS. When the Task Force
was convened, only ASHP-accredited
postgraduate year one (PGY-1) pharmacy
residency positions were eligible. This limitation
in funding eligibility was invoked in 2003, when
funding was retracted for postgraduate year two
(PGY-2) pharmacy residency programs.4 An
additional element for funding eligibility is that
the provider’s allowable educational costs cannot
include costs that represent a redistribution of
costs from an educational institution to a
provider. Nor can it include costs that have been,
or are currently, provided through community
support.5 For example, if a pharmacy residency
was previously or is currently receiving financial
support from a college of pharmacy (COP), this
cost cannot then be shifted to the provider. In
addition, CMS views “community support” as any
funding that is non-Medicare (other than
payments made for providing services to
individual patients), including state and local
government appropriations. Certain grants, gifts,
and endowments are not viewed as community
support and are allowable (section 1134 of the
Act).
Two categories of allied health postgraduate
educational programs may be eligible for CMS
pass-through payments: “provider-operated
programs” and certain “non–provider-operated
programs.”5 Provider-operated programs include
traditional hospital-based PGY-1 pharmacy
residency programs. The provider must incur the
training costs, have direct control of the
curriculum, control the administration of the
program, employ the teaching staff, and issue the
certificate for successful completion of the
training program. Non–provider-operated
programs include programs administered by an
educational institution that is related to the
provider by common ownership or control. For
example, a hospital (or group of hospitals in a
community) may create an educational
foundation to administer postgraduate training
programs (medical and/or allied health) in an
effort to improve efficiency and minimize
duplicative administrative functions. A pharmacy
residency program operated by such a foundation
would be viewed as a non–provider-operated
program. Similarly, a non–provider-operated
program would have to incur the training costs,
control the curriculum, etc., as noted above. In
general, receiving CMS pass-through payments
for a provider-operated program is more
straightforward.
Both the CMS regulations pertaining to GME
funds and the process for requesting them are
rather complex. Enlisting the support and
expertise of individuals at the practice site who
are responsible for generating the Medicare cost
report is essential. Included in this annual cost
report are data on total gross charges, gross and
net revenue, expenses, payer mix, and patient
visits. A request for GME funds for a pharmacy
residency will be included in the Medicare cost
report. Payment for a provider’s net cost for
allied health educational activities is determined
on a reasonable cost basis,6 including trainee
stipends, compensation of instructors, and other
costs of clinical training. Net costs reported to
CMS for Medicare pass-through funds are subject
to apportionment for Medicare use,7 a process
meant to ensure that the cost of services for non-
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Medicare beneficiaries is not borne by CMS.
This adjustment reflects the varying Medicare
patient load among providers. Therefore, a
residency program at a provider with a higher
Medicare patient load will be eligible for a higher
amount of Medicare pass-through funds (see
Table 1). Readers are encouraged to review
Appendix 1, as well as the article by Miller and
Woller, which provides an excellent overview of
GME reimbursement for pharmacy residents.3
Although not eligible for CMS funding,
training conducted in federal facilities may have
additional resource opportunities. The Veterans
Affairs Medical Centers (VAMCs) trained 22% of
all pharmacy residents in the United States in
2008–2009. This number is expected to grow
after the office’s issuance of a funding request for
an additional 80 residency positions through the
year 2014.8 With programs at 89 of the 155
VAMC locations, funding for all pharmacy
residency positions emanates from the VA
Central Office in Washington, D.C. All VAMC
residency programs must be accredited by ASHP
to be eligible for VA funding, which includes
resident stipends and excludes related travel
expenses.
State and Local Sources
Local partnerships may be identified for
collaborations that support residency education,
which results in program cost sharing (Table 2).
COPs are frequently supporters of postgraduate
residency training.9 In 2002, the American
Association of Colleges of Pharmacy (AACP)
asserted that pharmacy residency training should
be included in the mission of all member
institutions, thus emphasizing the support of
academic pharmacy for residency training.10 An
investment in residency training can yield future
dividends to the academic organization beyond
the short-term support of educational and
research missions. For example, residents who
eventually become faculty members are more
likely to have acquired training and experience in
teaching methods during their residency.11 As a
result, COPs may be simultaneously supporting
the development of their future faculty members
when they participate in residency training.
State pharmacy associations may also be
interested in supporting and promoting residency
education, to advance the level of pharmacy
practice in the state or possibly to support
legislative advocacy efforts. Grants from the
pharmaceutical industry, professional pharmacy
societies, and other educational foundations are
other sources to consider.9 Individuals seeking
financial support for residency training should
recognize that funds may be available from
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Table 1. Sample Budget of Total Education Costs for a PGY-1 Pharmacy Residency with Two Pharmacy
Residents
Cost Item Calculation Cost ($)
Direct costs
Resident
Salary + benefits ($42,000 + 25% benefits) x 2 105,000
persons = $52,500/person
Travel $2000 2000
Research poster preparation $600 600
ASHP annual accreditation fee $2650 2650
Teaching time
Program director (20% of salary + benefits)a 24,551
Administrative time for program director (5% of salary + benefits) 6137
Clinical pharmacy specialist (rotation preceptor)—teaching time (25% salary + benefits) × 2 61,377
preceptors
Clinical pharmacy staff (rotation preceptor)—administrative time (5% salary + benefits) × 2 12,276
preceptors
Preceptor travel to residency conference/recruitment 4000
Total direct costs 218,591
Indirect costs (30% of total direct costs)b 72,945
Total educational costs 316,095
Anticipated Medicare reimbursement Hospital has 53% of patient
load with Medicare patients
(total education costs ×
Medicare patient load) 167,530
aTime in which staff is directly involved with teaching residents.
bThis percent is derived from the Medicare step-down method for determining cost.
ASHP = American Society of Health-System Pharmacists; PGY-1 = postgraduate year one.
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certain organizations even if there is no routine
call for applications; thus, directly
communicating with representatives from these
organizations can be productive.
Some state Medicaid programs provide support
to learners in the health professions; they should
be contacted to determine potential eligibility.
An example is the Medical Education and
Research Costs Fund established in Minnesota in
1996.12 The purpose of this fund is to
compensate hospitals and clinics for a portion of
the costs of clinical training. The program was
developed to address costs that had traditionally
been covered by teaching facilities charging
higher rates for patient care but that had become
difficult to recoup as third-party payers reduced
payments to teaching facilities. The amount of
funds received is related to the amount of public
program revenue received by the institution. For
the COP at the University of Minnesota, this
program generates between $5000 and $25,000
per resident full-time equivalent (FTEs) per year.
Expanded Revenue Opportunities
Pharmacy residents play a key role in assisting
an organization in meeting its goals with respect
to medication use, safety, and the delivery of
medication therapy management (MTM) services.
The primary role of a resident is certainly as a
“learner”; however, because this learning is
inextricably intertwined with the delivery of
pharmacy services through experience-based
learning, it is difficult to draw the line between
the learning activities (which require dedicated
resources) and the services provided (which add
to the department’s or organization’s cumulative
resources). Nonetheless, the services provided by
residents yield opportunities for revenue
enhancement.
Clinical Service Contributions
Residents contribute to the underlying mission
of an organization by providing patient care (e.g.,
patient care rounds, target drug monitoring,
patient monitoring), as well as by extending
pharmacy services, conducting research,
providing education, facilitating
leadership/management activities, and engaging
in community service. One of the most common
forms of such contributions is direct participation
in the medication use system (e.g., pharmacist
staffing, distributive activities). The importance
of staffing to the growth of a resident is
highlighted by specific requirements within the
ASHP accreditation standards, including training
outcomes for the ability to manage and improve
the medication use system as well as use medical
informatics. A specific goal that PGY-1 residents
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Table 2. Sample Budget for a PGY-1 Community Pharmacy Residency
Budget Item Notes Cost ($)
Expenses
Resident – salary + benefits $40,000 + 20% benefits 48,000
Resident – travel Stipend for one national meeting 1000
ASHP accreditation fee Fee assessed for one program with one site 2875
Program director, admin effort (5% of salary + 25% benefits) 5750
Preceptor(s), teaching effort (20% of salary + 25% benefits) 21,000
Marketing and recruitment expenses Printed marketing materials, travel to national meeting 2000
Total direct costs 80,625
Revenues and Net Savings
Patient care revenues Based on 10 encounters per week 24,000
Net staffing contribution Based on 20% staffing contribution; net
difference between resident salary and
staff pharmacist salary 16,650
Compensation from Pharm.D. 2 × 1-month rotation; $1000/rotation
program for teaching effort Resident laboratory teaching at college $1000 3000
Total revenues/Net savings 43,650
Indirect costs (30% of total direct costs, if considered by the institution) 24,187
Net costs 61,162
admin = administrative; ASHP = American Society of Health-System Pharmacists; PGY-1 = postgraduate year one.
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must achieve is preparing and dispensing
medications following existing standards of
practice and an organization’s policies and
procedures. A 2000 survey characterized the
average distributive requirement as an average of
8 hours/week (range 3.5–16 hours/week) for
both PGY-1 and PGY-2 specialty residents.13
This same investigation revealed that the
activities performed by residents to cultivate this
skill set were not solely represented by direct
participation in traditional drug distribution
activities. Duties performed will depend on the
practice model employed by the organization, as
well as specific institutional needs. For example,
in a health system practice model that
incorporates floor-based decentralized
pharmacists with direct patient care
responsibilities (e.g., rounding, therapeutic drug
monitoring, collaborative practice), residents
may be expected to fulfill pharmacist shifts in
either the central pharmacy or decentralized
areas or in some combination of both.
Staffing requirements can be tailored not only
to meet the training needs of the resident, but
also to help address the critical components of
the scope of services delivered by a pharmacy
department, which may include expectations for
residents to provide staffing on evenings and
weekends—times for which securing staff
pharmacist coverage may be challenging.
Residents also often fulfill service obligations
during holidays. In rare instances, residents may
also help cover night shifts or sick calls, as long
as such events do not adversely affect the
educational experience of the resident or violate
the guidelines related to duty hours. Engaging
residents in traditional pharmacist roles can also
assist in justifying the cost of providing residency
training. Any shift completed by a resident is
one less shift provided by a staff pharmacist;
thus, one cost-justification approach is to
calculate the direct replacement of pharmacist
wages for shifts fulfilled by residents. For
example, if a group of four pharmacy residents
typically staffs 32 hours a week and pharmacist
wages average $50/hour, the net gain to the
department over 12 months (excluding 1 month
of orientation and training) is $17,600. This
amount may increase when pay differentials for
evenings and holidays are considered.
Pharmacy residents can also serve as service
extenders by providing a host of other patient
care services, such as completing high-cost drug
review (e.g., prior approval), providing
antimicrobial stewardship, conducting
medication reconciliation, providing MTM
services, documenting patient interventions,
charging for services, and completing discharge
histories. Acute care institutions often struggle
to provide high-level care at all times,
particularly on evenings, weekends, and
holidays. One pharmacy department reported its
experience with optimizing patient outcomes
through a 24-hour on-call policy. All pharmacy
residents in this program provided guidance on
serum drug concentrations, pharmacokinetic
monitoring, drug information, drug therapy
evaluation, and emergency patient treatment, and
they obtained medication histories in
conjunction with their distributive
responsibilities.14 Other organizations have
implemented around-the-clock on-call programs
in which residents are available for consultation
by telephone or pager. Another example of
residents contributing to expanded service
capacity is their integration with teams
responding to medical emergencies. A recent
survey identified that when considering required
and optional medical emergency response
patterns, the extent of participation by pharmacy
residents in medical emergencies exceeded that
of their staff pharmacist colleagues.15
Pharmacists, including pharmacy residents,
may be able to directly bill for clinical services,
particularly in the outpatient setting.
Opportunities include Medicare Part D, certain
state Medicaid programs, and local programs.
One example is the Iowa Medicaid
Pharmaceutical Case Management Program. As
licensed pharmacists, pharmacy residents are
able to see eligible patients and directly bill for
their services, contributing to the patient care
revenues generated by an organization. The
additional service capacity that can increase
opportunities for clinical revenues may expand
to other areas. For example, one program
created learning opportunities for pharmacy
residents in a long-term care project, serving as
consultants, which provided additional revenue
to the program.16
Administrative Service Support
Pharmacy residents contribute to
organizational and departmental leadership and
management activities and may serve on
committees, become involved in formulary
review, or have chief or lead resident
responsibilities that limit the administrative role
of the pharmacy staff.17 In 1982, Schneider and
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colleagues prepared a cost-justification evaluation
of a hospital pharmacy residency training
program.18 The contributions of pharmacy
residents were tabulated and compared with the
cost of the program to the hospital (i.e., salaries,
fringe benefits, and training expense). Residents’
activities that benefited the organization included
the provision of administrative support, the
completion of special projects, scheduling staff
assignments, and coordinating educational
programs. Resident contributions exceeded costs
of training by a 1.3:1 ratio. Another important
organizational contribution residents provide is
support of the residency program recruitment
process.19 Other service roles may include
contributions to professional and community
service activities (e.g., local health screenings,
brown-bag activities, immunization drives).
Although not well quantified in the literature,
the overall contributions of residents in achieving
departmental or organizational goals can be
extrapolated from the value of staff pharmacists.
The Task Force believes that an appropriate
means by which to consider this is an evaluation
of the “multiplier effect” that residents can have
on the impact of pharmacy services within the
organization. Residents’ contributions often
extend the overall work by core pharmacy staff by
taking on projects, assuming certain patient care
roles so that staff can have the flexibility to accept
short- or long-term assignments within the
organization, and enhancing educational efforts
to both pharmacy and non-pharmacy audiences.
To evaluate the return on investment of hosting
pharmacy residents, one must consider the full
value of the services delivered by pharmacy
residents both directly and indirectly, divided by
the direct and indirect costs associated with
providing this educational experience. To
accurately define the numerator in this equation,
the full scope of the incremental increase in
service capacity within the organization must be
considered—which includes not only the services
directly delivered by residents, but also the
indirect impact of results realized through the
enhanced capacity of staff secondary to a
resident’s presence.
Additional Revenue Opportunities
The presence of residents may increase the
capacity of the pharmacy department to take on
externally funded projects, such as postmarketing
surveillance, formulary review work, or delivery
of after-hours services to remote institutions. In
some cases, the work related to these projects
may be completed directly by residents, or staff
pharmacists may complete the work because of
the increased flexibility in their time secondary to
the contributions of a resident. For example, one
institution received a contract for the
development and ongoing maintenance of a series
of therapeutic class monographs provided within
a Web-based formulary management tool. The
development and maintenance of the
monographs, completed by residents and
overseen by preceptors, created a positive
learning experience for residents and an
important revenue opportunity for the
department. Similarly, another program
developed a mechanism for supplementing funds
by requiring residents to write articles for a
column in a medical journal, an activity that also
provided excellent medical writing opportunities
for the trainees.20
Other institutions have integrated residents
into compensated activities that provide de-
identified patient data or “purchasing data” from
expert panels, manufacturers, or independent
researchers evaluating medication use patterns or
conducting postmarketing surveillance. The
preceptor identifies projects acceptable to the site
and seeks institutional review board or other
necessary approval to complete the work;
residents can assist with efforts to collect and
report the data. Finally, some programs have had
pharmacy residents assist with sponsored clinical
research activities. One organization has used
pharmacy residents as sub-investigators on drug
protocols. Residents assist in identifying
potentially eligible patients in addition to other
study-related functions, allowing the site to
increase its research capacity and, subsequently,
its research revenues.
Indirect Revenues
The previous section addressed many of the direct
service contributions made by residents and some of
the revenues realizable from these activities. The
following section presents examples of
opportunities in which the addition of pharmacy
residents can indirectly enhance organizational
revenues, an important consideration when
completing a global analysis of the value that
residency training can bring to an organization.
Increased Capacity of Medical Providers
Clinical pharmacy services provided by staff
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pharmacists or residents have the potential to
increase the efficiency of other providers,
allowing the medical staff opportunities to
increase the number of billable visits. Some
ambulatory care clinics have considered how
delegating activities such as medication refill
authorizations and non-billable work (e.g.,
telephonic patient follow-ups) by medical staff to
pharmacists may contribute to overall clinic
revenues. For example, in a medical clinic with
six FTEs of physician staff, if the clinic is able to
achieve one additional billable encounter per
week for each physician FTE, it could generate
an additional $45,000 in revenue (based on an
average of $150 per physician encounter).
Pharmacy residents working in collaboration
with a pharmacist preceptor in this environment
can substantially contribute to creating this
positive revenue for the practice.
Enhanced Revenues from Pay-for-Performance
Contracts
Many studies have documented the enhanced
achievement of clinical indicators when
pharmacists participate in the care provided by
an interprofessional team. The impact of this
may more frequently result in enhanced revenues
for ambulatory practice settings because of the
incentive payments realized through pay-for-
performance contracts. Although pharmacists
and/or residents do not directly generate these
enhanced revenues, their contribution to services
delivered by a team can play a considerable role
in achieving performance benchmarks. For
example, certain pay-for-performance contracts
provide incentive payments for reaching a
percentage of patients who have achieved clinical
goals for blood pressure, A1c, and cholesterol.
Pharmacy residents, working with a preceptor
and directly managing the treatment of patients
with diabetes, may increase the likelihood of the
practice reaching its prescribed benchmark. In
the inpatient setting, institutions more frequently
see payments withheld for adverse events (e.g.,
nosocomial infections) or early readmissions.
The presence of pharmacy residents likely
enhances the ability of a pharmacy department to
help prevent these undesirable events; this
contribution to the capacity of the department
should be considered when evaluating the value
of residency education to the institution.
Payments for Pharm.D. Education
Some COPs may pay affiliated organizations
for providing introductory or advanced
pharmacy practice experiences (IPPEs/APPEs).
The presence of pharmacy residents will likely
bolster the organization’s teaching capacity,
increasing the number of Pharm.D. students
hosted and, in turn, resulting in higher payments
from the school.21 Beyond the experiential
setting, some schools may provide a salary offset
to a sponsoring organization for residents who
serve as teaching assistants in didactic courses.
Contribution of Residency Training to Quality
and Cost Indicators
Safe, effective, and rational use of medications
leads to improved patient outcomes and reduced
costs. Outcomes may include reduced hospital
admissions and diagnostic testing, fewer
prescribing errors, lower morbidity and
mortality, decreased length of stay, prevention of
adverse drug events, and increased efficiency and
health education. The patient care efforts of
pharmacy residents may enhance the
achievement of such goals. Common patient
care activities range from providing
interventions; preventing, diagnosing, and
managing adverse drug events; and monitoring
patients to participating in collaborative practice
agreements and exercising prescriptive authority
(see “Clinical Service Contributions”).
Although the primary value of a residency
program stems from the perceived long-term
benefits to the patients and the profession,
evidence suggests that even during training,
pharmacy residents provide cost-beneficial
clinical services. Several studies show the
positive impact of pharmacy residents on drug
costs,22–24 prescribing errors,22 adverse events,25
and length of stay.22
Terceros and colleagues showed the positive
impact of a pharmacy resident in reducing the
hospital length of stay and producing drug-
related cost savings. In that study, a pharmacy
resident prospectively evaluated pharmacy
interventions in patients admitted to a general
medicine unit for 1 month and found that the net
drug-related cost savings totaled $2087,
compared with patients admitted to a team that
did not include a pharmacy resident. Most
interventions prevented adverse drug events and
prescribing errors and significantly lowered the
mean length of stay (p=0.008).22 The impact of a
PGY-1 resident in an assisted living facility was
prospectively evaluated in the context of MTM
activities for 184 days. The pharmacy resident
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made 125 recommendations to primary care
providers, 72 of which were addressed (90.3% of
these were accepted). The resulting net cost-
benefit was $1550, with a benefit-to-cost ratio of
1.7 and a return on investment of 70%.23
Hospital pharmacy residents also provide cost-
beneficial clinical services, as noted in a 1993
Canadian study.24 Interventions made by three
hospital pharmacy residents and the
corresponding workload of these individuals
during a 4-week period were used to compare the
cost of a resident providing direct patient care
services with the cost of a staff pharmacist. The
balance of the residents’ salaries and the partial
salaries of any pharmacists spending time with
the residents were also included. The
investigators determined that 52% of the
residents’ efforts were spent on education-related
activities and 32% on clinical services. Of the
interventions evaluated by a physician review
panel, 76% were considered to have a positive
impact on patient care, yielding a cost-to-benefit
ratio of 1.4 to 1 in favor of the residents. A study
by Arroyo and colleagues showed that the
integration of a pharmacy resident into a health
care team in a medical oncology intensive care
unit optimized therapy, reduced costs, prevented
adverse events, and produced health care
education.25 This Spanish study of 672 patients
over 8 months noted that the costs saved by
integrating the resident amounted to 3133 euros
per month (around $4091 in U.S. dollars).
Silva and colleagues studied the use of personal
digital assistants to document pharmacists’
cognitive services and estimate potential
reimbursement, determined by quantifying the
hypothetical reimbursement for each intervention
(e.g., allergy or disease state contraindications,
antimicrobial regimen changes, drug interactions,
elimination of duplicate therapy, therapeutic
consultations).26 For 6 months, four health
system pharmacy residents and four clinical
pharmacists recorded 7319 interventions, with
estimated clinical service revenues of $360,000.
Supportive examples can also be found in
ambulatory settings. Kent and colleagues showed
that the revenues for services exceeded their costs
in a wellness center when performed by a
pharmacist, a pharmacy resident, or a
pharmacist–pharmacy resident combination.27
Furthermore, two of the services (blood pressure
and glycosylated hemoglobin monitoring) had a
net financial gain only when a resident provided
the service. This study involved a retrospective
review of 1181 pharmacy wellness center records
over 24 months at an independent community
pharmacy.
Staff Recruitment, Development, and
Satisfaction
Residents can have both a direct and indirect
impact on pharmacy staff recruitment, retention,
and development.
Recruitment
Residency programs can serve as an internal
“feeder system” for new and vacant positions
within the institution by providing a known
talent pool of local candidates prepared to
contribute immediately to that particular work
environment. When there is a sustained shortage
of pharmacists to fill vacancies, investing in the
growth of internal employees to fill the pipeline
becomes particularly desirable. It is more costly
to recruit, orient, and provide shift-specific
training for an outside candidate. In a 2006
article on human resources management, Weber
shared that The University of Pittsburgh Medical
Center estimated that it cost the institution
$65,000 to hire and train a pharmacist, regardless
of his or her experience.28 Outside candidates
generally also require a longer training period,
which further delays the fulfillment of open
shifts.
The mere existence of a residency program is
also a surrogate marker of excellence and may
attract other highly skilled employees.
Employment in a setting in which teaching is a
focus or residency programs are conducted has
been promoted to students as the sign of a quality
work environment. Having a residency program
at the worksite promotes the personal and
professional development of the pharmacists
involved in educating the residents. Pharmacists
may be attracted to a department that provides
the opportunity to train residents because they
gain job satisfaction from “paying it forward,”
sharing their practice experience and mentoring a
future generation of pharmacists.
In a joint ASHP/AACP survey of hospitals’
capacity to host pharmacy students for
experiential training, there was a significant
relationship between an ASHP-accredited
residency being in place and the site’s
participation in providing experiential training.
Of the hospitals with residency programs, 66%
stated that residents were preceptors for IPPEs
and APPEs.29 Residents expand the preceptor
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base, allowing the site to accommodate more
students for introductory or advanced
experiential requirements, which in turn may
increase the organization’s exposure to soon-to-
be graduates and positively affect recruitment
efforts.
Job Satisfaction and Retention
When a residency program is in place, the level
of practice is raised for all pharmacists working
at that site. Because accreditation processes for
residencies evaluate the learning environment,
the site is held accountable for its practice model,
services, and facilities as outlined in ASHP
standards. This peer-reviewed, learning-focused
environment is more likely to promote
workplace energy, practice reflection and
innovation, and dedication to quality
improvement. Resident projects that advance or
improve patient care or departmental functions
may enhance the job satisfaction and
advancement of the pharmacists working at those
sites. Recruitment of current residents may
increase retention and loyalty because it
demonstrates to the staff the employer’s
commitment to the growth of its employees.30
Recently graduated residents are usually eager to
help develop near-peers and may look for a
worksite with an opportunity to participate in
residency education.
Staff Development
Residency training also provides a mechanism
for staff development. Residents are responsible
for delivering education as part of their learning
objectives, which, in many programs, occurs
through regular presentations as part of
departmental inservice or continuing education
programming. In some cases, residents may be
responsible for the planning and organization of
these programs. In addition, residents’ main
projects or administrative responsibilities may
involve staff development or training programs
for pharmacists, technicians, or students. Once
competent in the responsibilities of a given
position, the resident may also train new hires.
Although residents may primarily be responsible
for the training of technicians and interns, they
may also be involved in the shared training of
pharmacists.
The collateral benefits of residents as learners
may affect other staff members as well.
Preceptors are required to improve their own
skill set and knowledge base continually so that
they can be effective teachers. Through contact
with residents, staff members may choose to
pursue a course of advanced training or
certification that they would not have otherwise
considered. Residents may establish certification
and credentialing program study groups and thus
may benefit fellow residents and pharmacists
alike.
Increased Capacity to Deliver Education and
Scholarship
Residency programs allow residents to lead a
plethora of educational programs, resulting in
the education of pharmacists, pharmacy
technicians, nurses, physicians, and other
individuals in the organization. ASHP has
established goals related to teaching skills within
its accreditation standards for both preceptors
and residents. Part of the ASHP residency
training requirements includes the resident’s
ability to provide education to various groups, in
both large and small formats. The benefits of this
increased capacity to deliver staff learning
opportunities are described above.
Another outcome of this expectation for
residents to engage in teaching activities is that
pharmacy residents may have formal COP
didactic or experiential teaching responsibilities
and may be involved in leading lectures, small
group discussions, and laboratory sessions and in
precepting students and residents. A recent
survey determined that one of the elements
reflective of a satisfactory relationship between
COPs and academic medical centers was student-
resident integration.31 Another survey finding
was that residents provide a variety of teaching
activities such as leading small groups,
instructing large classes, precepting students,
leading weekly conferences, facilitating clinical
examinations, assisting the primary preceptor,
and discussing the role of residency training in
educational sessions. COP-affiliated residency
programs increase the capacity of organizations
to provide experiential education, both at the
introductory (IPPE) and advanced (APPE) level.
Residents support the expansion of experiential
training at sites by conducting student
educational discussions, patient reviews, and
evaluation processes involved with these
experiences; serving as initial facilitators for
students as they perform their patient care duties;
and fulfilling other preceptor roles.
Some college-affiliated programs offer elective
academic rotations for the residents to complete,
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whereas others feature teaching skill development
programs (e.g., teaching certificate programs) in
their structure. These programs often include
formal seminars on teaching-related topics as well
as small group and didactic evaluated teaching
and the submission of a teaching portfolio.32
These teaching skill development programs are
often designed to prepare residents for formal
teaching positions. However, new faculty,
preceptors, and other practitioners may also
benefit from enrolling and cultivating their
abilities to teach in the practice setting. Faculty
members also benefit from resident-delivered
activities. Precepting residents is a desirable
activity for many clinical faculty members, as
residents can broaden their level of teaching and
bring the discussions to a higher level of clinical
expertise and challenge. Scholarship capacity
also expands by creating faculty-resident
collaborations on scholarly efforts or freeing
faculty members from clinical service to focus on
their own scholarly endeavors.
According to the ASHP residency accreditation
standards, residents are required to cultivate their
own project management skills. Such skill
development may take the form of formal
research, continuous quality improvement
initiatives, medication use evaluations, or practice
service implementation (e.g., protocol
implementation with measurement of impact, or
quality assurance initiatives) that benefits the
host organization. Engaging other pharmacists in
resident projects can subsequently develop
residents’ own research abilities.
Support of Innovation
The Institute of Medicine (IOM) has issued
several reports emphasizing the need for
improved health care education. The IOM has
also recognized that although many health care
professionals are expected to work within
interdisciplinary teams, they have often not been
prepared to do so. The purpose and design of
pharmacy residency programs are well suited for
both of these roles, as residents often work in
collaboration with their health care colleagues to
provide patient care. Organizations that host
residency programs are often a laboratory for
innovations in patient care delivery.
Establishment of New Services
Pharmacy residents can be instrumental in
establishing patient care efforts in new patient
populations or practice settings. Supporting this,
residents may conduct a needs assessment related
to a new service or provide limited services when
the service is initially established. Such an
approach has been successful in emergency
departments, where the assessment of need or
provision of initial limited services has led to a
call for establishing a newly funded position and
often the subsequent hiring of the resident
graduate for the new position.33 Opportunities
also exist to engage residents in establishing new
services in the community and ambulatory
setting. Efforts have included establishing
immunization programs, MTM initiatives,
medication adherence clinics, and specialty
clinics (e.g., lipid management, chronic pain,
solid-organ transplantation).
These innovations are often recognized
nationally by professional organizations. Over a
6-year period, four recipients of the ASHP Best
Practices Award were recognized for establishing
or expanding pharmacy services that involved
residents. Most of these pertained to ambulatory
clinics in which residents contributed
substantially to the services provided and whose
role was integral in the ability of the pharmacy
department to develop those services. Another
example is an institution that was able to
implement a pharmacist in a renal dialysis unit by
receiving a grant to fund a resident position.
Additional examples can be found with the
winners of the AACP Crystal Apple awards. This
award was designed to increase the capacity and
enhance the quality, efficiency, and effectiveness
of professional experience programs and to
improve pharmacy education and practice. In the
2 years since the program’s inception, most of the
award recipients have engaged pharmacy
residents through COP collaboration to achieve
these goals.
For organizations seeking support for residency
program development, abstracts presented at
national meetings for regional residency
conferences can be a source of ideas and
experience. Recent abstracts have featured
several resident-led initiatives around disease
management (e.g., diabetes, lipids, blood
pressure, renal care, chronic pain, chronic lung
disease, osteoporosis, anticoagulation),
medication reconciliation, procedural
interventions, medication adherence monitoring,
and adverse drug event monitoring. Many
examples of innovative resident projects designed
to improve the quality of patient care can also be
found in the literature.15, 34–41
500e
VALUE OF RESIDENCY TRAINING ACCP
Other Resources
Throughout this document, the Task Force has
brought together several sources of
information—published, anecdotal, and
hypothetical—describing the value of residency
education from the perspective of a sponsoring
organization. Individuals taking responsibility
for developing a value assessment for either
initiating or expanding a residency program (see
Appendix 2) should seek other sources of
information that will not only support efforts in
justifying residency positions, but also inform
them about the educational goals and objectives
that must be met to ensure residency program
quality. ASHP resources include the
organization’s Web site, the staff within the
Accreditation Services Division, the biannual
ASHP National Residency Preceptors Conference
(with proceedings published in the American
Journal of Health-System Pharmacy), and other
national meeting materials posted on the ASHP
Web site. APhA also provides resources to
organizations, particularly those seeking to
establish community pharmacy residencies,
through the APhA Web site and through staff
support. Many national organization meetings
hosted by ACCP, ASHP, and APhA include
presentations and workshops related to residency
programs and their development. Finally,
individuals looking to take a leadership role with
the expansion of residency training are highly
encouraged to seek networking opportunities in
their local area with pharmacists who have been
involved in residency training and can provide a
local source of information and support.
Future Directions
Although this document assists individuals in
justifying the expansion or development of
residency positions, new models for delivery of
practice-based education may need to be
considered to provide the profession with the
number of positions required to achieve ACCP’s
vision of residency training as a prerequisite for
direct patient care. Specifically, the medical
model of experiential teaching should be
explored. A hierarchical approach—from the
attending pharmacist to the PGY-2 resident to
the PGY-1 resident to APPE and IPPE students—
would allow learners to observe modeling and be
coached by pharmacists at various stages of
experience.42 Clinical pharmacists currently
committed to APPE and IPPE training may be
partly relieved of these responsibilities by
including residents in the training of IPPE
students. This may allow the clinical pharmacist
to mentor additional residents and increase
overall training capacity. Although preceptor
qualifications and state board regulations may
influence the ability to pursue such a model, the
Task Force encourages institutions that may have
used such a model to share their experiences and
report associated educational outcomes.
Conclusion
If the vision for residency training as a
prerequisite for direct patient care is to become a
reality, the pharmacy practice community must
embrace responsibility for delivering quality
residency training. In doing so, the profession
will not only support the development of
outstanding practitioners poised to meet the
medication use needs of the U.S. health care
system, but also simultaneously advance the
current contributions of pharmacy programs to
the delivery of safe and effective patient care.
The value realized by a sponsoring organization
involved in delivering residency training is broad
in scope and, as a result, somewhat challenging
to quantify. However, several forms of evidence
support residency education as an initiative that
provides a win-win partnership between resident
learners and host organizations and that
ultimately benefits the profession as a whole and
its mission to serve the drug-related needs of
society.
Acknowledgments
The Task Force would like to thank Jill S.
Burkiewicz, Pharm.D., BCPS, and Curtis E. Haas,
Pharm.D., FCCP, BCPS, for their assistance with this
document.
References
1. Murphy JE, Nappi JM, Bosso JA, et al. ACCP position
statement. American College of Clinical Pharmacy’s vision of
the future: Postgraduate pharmacy residency training as a
prerequisite for direct patient care. Pharmacotherapy
2006;26:722–33.
2. American Society of Health-System Pharmacists. ASHP
Health-system Pharmacy 2015 initative. Available from
www.ashp.org/Import/PRACTICEANDPOLICY/2015Initiative.a
spx. Accessed February 10, 2010.
3. Miller DE, Woller TW. Understanding reimbursement for
pharmacy residents. Am J Health Syst Pharm 1998;55:1620–3.
4. Medicare Program (U.S.). Changes to the hospital inpatient
prospective payment systems and fiscal year 2004 rates. Federal
Register. August 1, 2003;68:45423.
5. Anonymous. Cost of approved and nursing and allied health
education activities, 42 C.F.R. Sect. 413.85 (2006).
6. Anonymous. Adequate cost data and cost finding. 42 C.F.R.
Sect. 413.24 (2006).
501e
PHARMACOTHERAPY Volume 30, December 2010
7. Anonymous. Apportionment of allowable costs. 42 C.F.R. Sect.
413.50 (2006).
8. American Society of Health-System Pharmacists. No
accreditation? No funding says VA. InterSections
2009;Winter:10–1.
9. American Society of Health-System Pharmacists. Proceedings
of the 2008 ASHP National Residency Preceptors Conference.
Am J Health Syst Pharm 2009;66:e51–5.
10. Lee M, Bennett M, Chase P, et al . Final report and
recommendations of the 2002 AACP task force on the role of
colleges and schools in residency training. Am J Pharm Educ
2004;68(Suppl 2):1–19.
11. McNatty D, Cox CD, Seifert CF. Assessment of teaching
experiences completed during accredited pharmacy residency
programs. Am J Pharm Educ 2007;71:88.
12. Minnesota Department of Health [Internet]. Medical education
and research costs (MERC). St. Paul, MN: Minnesota
Department of Health, 2009. Available from
www.health.state.mn.us/divs/hpsc/hep/merc/. Accessed
February 10, 2010.
13. Jennings HR, Empey PE, Smith KM. Benchmarking ASHP-
accredited residencies: a survey of program stipends, benefits,
staffing practices and organization. Am J Health Syst Pharm
2000;57:2080–6.
14. Smith KM, Hecht KA, Armitstead JA, Davis GA. Evolution and
operation of a pharmacy residency on-call program. Am J
Health Syst Pharm 2003;60:2236–41.
15. Toma MB, Winstead PS, Smith KM, Lewis DA, Clifford TM.
Pharmacy resident participation in cardiopulmonary
resuscitation events. Am J Health Syst Pharm 2007;64:747–53.
16. Horning KK, Hoehns JD, Doucette W. Adherence to clinical
practice guidelines for 7 chronic conditions in long-term care
patients who received pharmacist disease management services
versus traditional drug regimen review. J Manag Care Pharm
2007;13:28–36.
17. Burkiewicz JS, Bruce SP. Chief resident in pharmacy residency
programs. Am J Health Syst Pharm 2007;64:754–61.
18. Schneider PJ, Bowman DM, Bourret JA, Ngu BQ, Ouellette
SM, Smeek DM. Cost justifying a pharmacy residency program.
Am J Hosp Pharm 1982;39:1517–20.
19. Ramsey EZ, Miller AD, Armitstead JA, Smith KM. Using
pharmacy residency recruitment as a practical learning
experience for existing residents. Am J Health Syst Pharm
2009;66:329–32.
20. Smith KM, Romanelli F. Use of an electronic survey to assess
the training and practice experiences of pharmacy residency
graduates. Am J Health Syst Pharm 2005;62:2283–8.
21. Smith KM, Phelps PK, Mazur JE, May JR. Relationships
between colleges of pharmacy and academic medical centers.
Am J Health Syst Pharm 2008;65:1750–4.
22. Terceros Y, Chahine-Chakhtoura C, Malinowski JE, Rickley
WF. Impact of a pharmacy resident on hospital length of stay
and drug-related costs. Ann Pharmacother 2007;41:742–8.
23. Maack B, Miller DR, Johnson T, Dewey M. Economic impact of
a pharmacy resident in an assisted living facility-based
medication therapy management program. Ann Pharmacother
2008;42:1613–20.
24. Yoshida E. Workload and cost-benefit of hospital pharmacy
residents. Can J Hosp Pharm 1993;46:147–54.
25. Arroyo CC, Aquerreta I, Ortega EA, Goni ZO, Giraldez DJ.
[Clinical and economic impact of the pharmacy resident
incorporation into the healthcare team]. Farm Hosp
2006;30:284–90. Spanish.
26. Silva MA, Tataronis GR, Maas B. Using personal digital
assistants to document pharmacist cognitive services and
estimate potential reimbursement. Am J Health Syst Pharm
2003;60:911–5.
27. Kent K, McDonough RP, Dinges B, Doucette WR .
Retrospective financial analysis of wellness center from an
independent community pharmacy perspective. J Am Pharm
Assoc 2006;46:447–52.
28. Weber RJ. Human resources management for the pharmacy
director. Hosp Pharm 2006;41:1206–14.
29. Anonymous. Capacity of hospitals to partner with academia to
meet experiential education requirements for pharmacy
students. Am J Pharm Educ 2008;72:117.
30. American Society of Health-System Pharmacists. ASHP
guidelines on the recruitment, selection, and retention of
pharmacy personnel. Am J Health Syst Pharm 2003;60:587–93.
31. Smith KM, Patton LR, Cannon BC, Romanelli F. Status of
teaching skill development programs (TSDPs) in pharmacy
residencies [abstract]. Am J Pharm Educ 2008;72:Article 72.
32. Romanelli F, Smith KM, Brandt BF. Teaching residents how to
teach: a scholarship of teaching and learning certificate program
(STLC) for pharmacy residents. Am J Pharm Educ
2005;69:126–32.
33. Weant KA, Sterling E, Winstead PS, Armitstead JA, Boggs R.
Establishing a pharmacy presence in the ED. Am J Emerg Med
2006;24:514–5.
34. Smith KM, Lawson AP, Tuteja S. Effect of internal reporting
criteria on suspected adverse drug reactions submitted to
MedWatch. Am J Health Syst Pharm 2006;63:949–52.
35. Smith KM, Trapskin PJ, Empey PE, Hecht KA, Armitstead JA.
Internally developed online adverse drug reaction and
medication error reporting systems. Hosp Pharm 2006;41:428–
36.
36. Sterling ES, Romanelli F, Martin CA, Hoven AD, Smith KM.
Impact of a pharmacy-initiated HIV admission note on
medication errors within an academic hospital. Hosp Pharm
2005;40:874–81.
37. Trapskin PJ, Smith KM, Armitstead JA, Davis GA. Use of an
audience response system to introduce an anticoagulation guide
to physicians, pharmacists and pharmacy students. Am J Pharm
Educ 2005;69:190–7.
38. Vincent WR, Martin CA, Winstead PS, Smith KM, Gatz J,
Lewis DA. Effects of a pharmacist-to-dose computerized
request on promptness of antimicrobial therapy. J Am Med
Inform Assoc 2009;16:47–53.
39. Weant KA, Smith KM, Lewis DA. Assessment of prescriber
compliance with established heart failure guidelines at a major
medical center. Hosp Pharm 2005;40:680–6.
40. Yam FK, Akers WS, Ferraris VA, et al. Interventions to
improve guidelines compliance following coronary artery
bypass grafting. Surgery 2006;140:541–2.
41. Zarbock SD, Steinke D, Hatton J, Magnuson B, Smith KM,
Cook AM. Successful enteral nutritional support in the
neurocritical care unit. Neurocrit Care 2008;9:210–6.
42. Allen DD, Smith KM. A hand and glove approach to pharmacy
experiential education and residency training. Am J Pharm Ed.
2010;74(4):Article 65.
502e
VALUE OF RESIDENCY TRAINING ACCP 503e
Appendix 1. Frequently Asked Questions About Medicare Pass-through Funding for
Pharmacy Residencies
Question:What is Medicare pass-through funding (PTF)?
Answer: Medicare PTF is a source of federal funding to underwrite the cost to a site to conduct
residency training. Designed to support institutional costs of providing care to the Medicare
patient population, PTF primarily underwrites training in medicine and podiatry. Although no
longer an option for postgraduate year two (PGY-2) programs, PTF is currently available to
support accredited postgraduate year one (PGY-1) pharmacy residency programs.
Question:Which programs are eligible for PTF?
Answer: Sites are eligible for PTF if they sponsor a provider-operated program, characterized as
follows: directly incurring the training costs, controlling the curriculum, administering the
program, employing the teaching staff, and providing and controlling both clinical training and
classroom instruction.1 The Center for Medicare and Medicaid Services (CMS) currently limits
reimbursement to provider-operated programs delivered by hospitals. Despite the relatively
large number of programs that may be eligible for PTF, a 1998 survey revealed that only 44% of
pharmacy residency programs had applied for such funding.2
Question:What is a Medicare cost report?
Answer: Formally termed the Hospital Cost Report (CMS-2552-96), the Medicare cost report is
a large annual financial report that a Medicare-certified institutional provider (i.e., hospital) is
required to submit to a Medicare fiscal intermediary (FI). Included in this cost report are data
on total gross charges, gross and net revenue, expenses, payer mix, and patient visits. A
request for graduate medical education funds for residency training should be included in this
Medicare cost report. Hospital Cost Report data files since 1996 are available for downloading
from the CMS Web site at http://www.cms.hhs.gov/CostReports/ free of charge, or they may be
purchased on DVD.
Question:What is a Medicare FI?
Answer: Medicare FIs are private companies that serve as CMS agents to facilitate the
administration of Medicare program rules.3 As required by section 911 of the Medicare
Prescription Drug Improvement and Modernization Act of 2003, CMS is replacing its current
claims payment contractors (FIs and carriers) with new contract entities called Medicare
Administrative Contractors (MACs). There are 15 regional MACs, which will cover most Part
A and Part B services (i.e., A/B MACs).4 Therefore, MAC is the current term used to denote
what was traditionally described as an FI. The MAC is the hospital’s point of contact for
questions pertaining to the Medicare cost report, claims, and payment; also, the MAC audits
and approves financial transactions for Medicare programs.
Question:Which local resources can assist in managing the PTF process?
Answer: Many larger hospitals employ a Medicare reimbursement specialist in the accounting
or finance division who is familiar with the institution’s Medicare cost report and the processes
related to it. Smaller sites may contract with an outside agent to provide similar services by
preparing and submitting the Medicare cost report. Residency program directors should keep
the institution’s Medicare reimbursement specialist regularly apprised of costs related to the
pharmacy residency, anticipated financial changes, and any change in accreditation status.5
Question: At which point in the residency implementation process should Medicare PTF be
sought?
Answer: Pharmacy residency programs must be accredited by the American Society of Health-
System Pharmacists (ASHP) to be eligible for PTF. The residency accreditation process often
takes at least 12 months. However, all expenses incurred from the date the program applied for
accreditation until the date accreditation was granted are eligible for reimbursement. The local
Medicare reimbursement specialist can submit an amended hospital cost report to seek
Medicare PTF for that period. Therefore, the earlier the initial application for accreditation is
submitted, the earlier the program is eligible for Medicare pass-through reimbursement.
Question: How long may it take from filing a Medicare cost report until reimbursement?
Answer: The hospital must submit the Medicare cost report no later than 5 months after fiscal
year-end. The MAC then has 60 days to determine a tentative settlement review related to the
cost report. Reimbursement from Medicare will usually begin within 1–2 months from the date
of the tentative settlement review. The hospital will then receive a payment each month
specifically for the allowable Medicare pass-through costs. Any monies due to or from
Medicare will be adjusted at the time of final audit by the MAC. Some hospitals may have a 2-
year audit time before final costs are settled with the MAC. Although it may take quite some
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time to receive PTF after initial residency start-up, program directors should not discount this
important funding source, but rather should be prepared for quite a delay in the process until
initial payment.
Question:Which program costs of the pharmacy residency are eligible for reimbursement?
Answer: Program costs that should be acceptable for PTF reimbursement include the
following: trainee stipends, teacher (e.g., preceptor) salaries, resident travel stipend, research
poster preparation, annual ASHP accreditation fee, photocopying services, and dues and
subscriptions. Reimbursements for teacher salaries are only allowable for the portion of the
preceptor’s time spent directly related to the residency program (e.g., teaching and
administrative). These direct costs, in addition to indirect costs, will be subject to Medicare
apportionment based on the hospital’s ratio of Medicare patient-days to total patient-days.
Thus, the larger the Medicare population the institution serves, the greater the potential value
of PTF. For example, if your institution’s ratio of Medicare patient-days to total patient-days is
47%, then you will be eligible for 47% of the direct costs of the program to be reimbursed by
PTF.
Question: What portion of the resident’s work time can be included in the Medicare cost
report?
Answer: The time the resident spends within the hospital performing approved program
activities will count as allowable time on the Medicare cost report. In contrast, if a resident
spends time providing services in an affiliated clinic or pharmacy that is physically located off
premises, it is possible (but not certain) that this time will not be eligible for pass-through
reimbursement, depending on how the hospital’s Medicare cost report is structured. In
general, time spent outside the hospital, even for approved program educational activities, will
not be eligible for Medicare PTF.
Question: Can the costs of a residency program be shared between more than one provider
(e.g., be divided between two Medicare cost reports)?
Answer: Yes, provided there are adequate time studies and no “double-counting” of reported
program costs.
Question: What key requirements must be met before a MAC will approve PTF for a pharmacy
residency?
Answer: In addition to the essential element of a provider-operated PGY-1 program that is
accredited by ASHP, the program must not represent a redistribution of costs. CMS defines this
term as “an attempt by a provider to increase the amount, or to expand the types, of the costs of
educational activities that are allowed for Medicare payment purposes by claiming costs that
previously were not claimed by the provider and were considered costs of an educational
institution.”6
Question:What variables affect the amount of PTF an institution may receive?
Answer: Both direct and indirect costs can be captured in PTF. Indirect costs are unique to
each hospital because they are derived from the Medicare step-down method for allocating cost.
Both direct and indirect costs must undergo Medicare apportionment, a reflection of the extent
(e.g., patient-days) of Medicare-related services provided by the institution.
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Appendix 2. Sample Business Plan to Create a Residency Program
Scenario: Hospital C, member of a network of community hospitals, proposes to develop a
postgraduate year one (PGY-1) pharmacy residency program.
Pharmacy Residency Business Plan
Hospital C
Overview
Pharmacy residency training has long been recognized as the premier mechanism for the
clinical and administrative training of pharmacists. The purpose of a pharmacy residency is to
prepare pharmacists for clinical practice by providing intensive exposure to a wide range of
patients during a 12-month period. A central theme of any pharmacy residency program in a
community health care system is the improvement of clinical services and optimization of
patient outcomes as the primary objective.
The benefits of pharmacy residency training are not limited to the resident. Institutions that
assume the responsibility of training pharmacy residents gain the benefit of additional
pharmacist staffing, expanded clinical programs, enhanced patient care services, and increased
clinical pharmacy savings in exchange for nominal salaries (stipends). Because of residents’
contributions to pharmacy staffing and clinical pharmacy interventions, Hospital C will realize
additional cost-avoidance savings. In addition, the Centers for Medicare and Medicaid Services
(CMS), which manages the Medicare program, reimburses for certain expenses associated with
the training and education of health care professionals including pharmacists, further
improving the cost-to-benefit ratio of resident training.
Currently, only two institutions within our health network have pharmacy residency training
programs. Developing a PGY-1 pharmacy residency program is an opportunity for Hospital C
to further its image as a leader within the network; hence, a PGY-1 pharmacy residency
program should be considered a critical part of Hospital C’s strategic plan to retain and recruit
pharmacists, reduce patient care costs, and benefit patient care.
Background
Pharmaceutical and supply costs represent major unrecoverable expenditures in a fixed
reimbursement setting. The current health care environment requires acute care institutions
and health care providers to maximize patient care services through the judicious and
appropriate use of resources. Leading health care institutions have recognized that well-
designed clinical pharmacy programs can help contain costs and have long included pharmacy
residency training in their program models. Since the restructuring of pharmacy education in
the mid-1990s, pharmacy residency training has become an increasingly sought-after and
important pharmacist credential. In recent years, the number of applicants has exceeded the
number of available programs. Today, the American Society of Health-System Pharmacists
(ASHP) maintains accreditation standards for residency training to ensure broad applicability
in any pharmacy practice setting. These standards are continually reviewed and revised to keep
pace with the dynamics of the profession. ASHP has formed partnerships with other pharmacy
associations (e.g., American College of Clinical Pharmacy [ACCP], Academy of Managed Care
Pharmacy [AMCP], American Pharmacists Association [APhA]) for the accreditation of
residencies.
PGY-1 pharmacy residency programs have been in place for 10 years at Hospital A (four
residents) and for 3 years at Hospital B (two residents), both affiliates of the health network
system. Residents at these programs have been integrated into the clinical and staff pharmacy
model and are responsible for providing inpatient drug distribution, decentralized patient care
services/interventions, and administrative activities including policy development and
formulary maintenance. At Hospital C, the clinical pharmacy program consists of a clinical
pharmacy manager, a clinical pharmacy specialist, and four clinical-staff pharmacists. Creating
a pharmacy practice residency program would add two members to the clinical model and
allow an expansion of clinical pharmacy services, including increased clinical pharmacy
interventions. During the previous fiscal year, the clinical pharmacy program at Hospital A
was responsible for $1,726,375 in pharmaceutical and supply cost avoidance and documented
10,404 clinical patient interventions resulting in an estimated $283,888 savings through cost
avoidance or improved patient outcomes.
Rationale and Benefits to Hospital C
Creating a PGY-1 pharmacy residency program provides Hospital C yet another avenue to
improve the health of the communities it serves and parallels the strategic plan of the
organization. This residency program will allow the Department of Pharmacy to improve and
enhance services in clinical, operational, and financial performance. This opportunity will
result in increased clinical pharmacy activities including inpatient drug distribution,
decentralized patient care services, and administrative activities and formulary maintenance.
Expansion of clinical pharmacy services into new patient care areas would also be possible,
PHARMACOTHERAPY Volume 30, November 2010506e
Appendix 2. (continued)
allowing increased clinical pharmacy interventions, improved pharmaceutical use, and
improved adverse drug reaction surveillance and avoidance. The combination of improved
patient care and judicious resource use would be expected to result in an increased cost savings
to the institution. In addition, as Hospital C continues to recruit new physician leaders from
academic institutions, providing collaborative opportunities with the medical staff will become
paramount. A pharmacy residency-training program will allow the Department of Pharmacy to
continue to establish and foster physician relations similar to those in academic institutions,
consequently increasing multidisciplinary interactions and improving patient care and safety.
Furthermore, personnel recruitment in the Department of Pharmacy has often been difficult for
Hospital C. An in-house pharmacy residency program would enhance the institutional image
of being the work environment of choice and provide the department with a renewable supply
of clinically trained pharmacists well oriented to the Hospital C system in the event of
personnel turnover or departmental service expansion. Finally, Hospital C is continually
looking for opportunities for strategic growth, both nationally and locally. The development of
a pharmacy residency program would allow Hospital C to become one of only three health
network institutions to participate in resident training, thus increasing its image as a network
leader. On a regional level, Hospital C would be recognized as the only community hospital
site for resident training in the area, thereby furthering its image of being the region’s leading
provider of pharmaceutical care.
Pharmacy Residency Mission
In partnership with our physicians and hospital staff, the primary mission of the pharmacy
residency program at Hospital C is to provide traditional and innovative therapies, ensuring
optimal patient care while upholding the mission and vision of Hospital C. The pharmacy
residency program as a division of the clinical pharmacy program will strive to provide cost-
effective patient care consistent with clinical quality and safety standards.
Activities of the PGY-1 Pharmacy Resident
• Provide centralized medication distribution services to inpatients.
• Participate in decentralized clinical pharmacy programs including:
— Renal Dosage Adjustment Service
— IV to PO Dosage Adjustment Service
— Pharmacokinetic Monitoring Service
— Smoking Cessation Counseling Program
— Adverse Drug Event Monitoring/Reporting/Prevention
— Toxic Laboratory Monitoring
— Patient Home Medication Review
— Inpatient/Discharge Medication Counseling
— Target Patient Profile Review
• Participate in multidisciplinary patient care activities including:
— Patient Care Rounds with Physicians
— Nursing Care Plans
• Develop policy and procedures for Department of Pharmacy and patient care topics as
needed.
• Develop seminars and training mechanisms targeted to physicians as needed.
• Develop seminars and nursing in-services on clinical and operational topics as needed.
• Develop seminars and pharmacy in-services on clinical and operational topics as needed.
• Be a resource center for nurse or physician drug information/therapeutic inquiries.
• Complete regular pharmacy formulary surveillance and participate in the annual formulary
review.
• Complete medication use evaluations, ensuring appropriate and cost-effective
pharmaceutical use.
• Participate in institutional and medical staff committees.
• Create new cost-savings initiatives to be added annually to Hospital C.
• Complete a pharmacy-initiated service or research project annually.
• Assist clinical pharmacy manager with supervision and teaching of doctor of pharmacy
students.
• Increase participation in community outreach programs.
• Promote Hospital C locally and nationally through state and national pharmacy
presentations.
Funding of Pharmacy Residency Programs
CMS reimburses a portion of the expenses associated with the training and education of
health care professionals. Currently, the costs of PGY-1 pharmacy residency programs are
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reimbursable under rules different from those that apply to medicine, osteopathy, dentistry,
and podiatry residency programs. Direct costs of medical education (e.g., allocated overhead
costs, salaries of residents) are excluded from the Medicare definition of inpatient operating
costs covered by the prospective pricing system (PPS). Thus, the direct costs of approved
medical education activities are not included in hospital-specific, regional, or national payment
rates to hospitals under the PPS, but they continue to be reimbursed on the basis of reasonable
costs. These expenses are often referred to as graduate medical education (GME) costs and are
sometimes called GME pass-through costs because they are not reimbursed on the basis of the
PPS but, rather, they pass through the PPS, thus avoiding the reimbursement limitations
imposed by the PPS.
The Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1985 changed the way
CMS pays for the direct costs of education for medical, osteopathic, dental, and podiatric
interns and residents, superseding a July 1985 regulation amendment that tied payments to
Medicare use. In general, this change reduced the amount of reimbursement hospitals could
receive for medical education. However, this change applied only to medical, osteopathic,
dental, and podiatry internship and residency programs, not to pharmacy residency programs
and other “recognized professional and paramedical educational and training programs.”
Pharmacy residency programs continue to be reimbursed by CMS on the basis of the older
rules for direct costs of medical education in place before 1985. Medicare reimbursement for
accredited pharmacy residency programs is much more straightforward than reimbursement for
medicine, osteopathy, and dentistry programs.
To determine a hospital’s Medicare reimbursement for the direct costs of medical education,
multiply the hospital’s average direct cost of medical education per resident by the number of
full-time-equivalent residents, and multiply that product by the proportion of total inpatient-
days used by Medicare patients. The Medicare regulation on the cost of educational activities
specifically identifies pharmacy residencies accredited by ASHP as approved programs for pass-
through reimbursement of educational costs. For this purpose, a hospital’s total cost includes
trainee stipends, compensation of preceptors (salaries), and other direct and indirect costs of
the activities.
Start-up Costs
The start-up costs of a PGY-1 pharmacy residency at Hospital C would include only a small
financial commitment. Specifically, the initial recruitment of residency applicants involves
participation at the ASHP Midyear Clinical Meeting (MCM), which occurs annually in
December. Thousands of pharmacists, current residents, and prospective residents participate
in this event. As part of this meeting, residency programs are allowed to present their
programs and interview candidates during designated times. After recruitment, additional
start-up costs would include the purchase of equipment and materials such as laptop
computers.
Initial Start-up Costs
ASHP MCM recruitment booth fee $450
Travel to ASHP MCM $3000
Laptops × 2 $3000
Total start-up costs $6450
MCM = Midyear Clinical Meeting.
Annual Financial Impact to Hospital C
Medicare will reimburse a portion of the annual direct and indirect costs associated with
pharmacy practice residency training by GME pass-through based on the Medicare patient-days
at Hospital C (60%). Projected support of a pharmacy practice residency program for the first
year will cost Hospital C about $103,950 in new direct educational expenses; however, 60% of
these expenses will be reimbursed retroactively from Medicare. In addition, preceptor time
(pharmacist salaries) will now be eligible for 60% reimbursement by GME pass-through,
thereby effectively reducing current pharmacy staff expenses incurred by Hospital C. Finally,
incorporating pharmacy residents into the Hospital C staffing model is expected to reduce the
use of pool pharmacy employees, resulting in a staffing cost avoidance of $33,280.
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New Expenses to Hospital C (Direct Educational Costs)
Two residents
Salary and benefitsa $91,000
Travel to ASHP MCM $3000
Travel to regional residency conference $1000
Recruiting efforts and accreditation costs
Travel to ASHP MCM (2 preceptors) $4000
ASHP MCM recruitment booth fee $450
Travel to regional residency conference (2 preceptors) $3000
Accreditation fee $1500
Total new cost $103,950
Existing Hospital C Expenses Eligible for Medicare Reimbursement (Indirect
Educational Costs)
Hours/
Teaching and administrative timeb Year Time (%) Cost
Director of pharmacy/ 160 7.7 $12,000
pharmacy manager
Clinical pharmacy manager 520 25.0 $32,500
Clinical pharmacy specialist 480 23.1 $28,500
Clinical-staff pharmacist #1 230 11.1 $12,938
Clinical-staff pharmacist #2 230 11.1 $12,938
Clinical-staff pharmacist #3 230 11.1 $12,938
Clinical-staff pharmacist #4 230 11.1 $12,938
Total existing costs eligible for
Medicare reimbursement $124,750
Reimbursement
Medicare reimbursement
Medicare
reimbursement Reimbursement
Medicare cost basis Cost (%) ($)
Direct educational costs ×
Medicare patient load $103,950 60 $62,370
Indirect educational costs ×
Medicare patient load $124,750 60 $74,850
Total Medicare reimbursement $137,220
Staffing contribution by residents
Staffing cost avoidance = 8 hours/week × 2 residents $33,280
Overall Financial Impact
Total new cost – $103,950
Total reimbursement from Medicare + $137,220
Staffing cost avoidance + $33,280
Net annual financial impact $66,550
aBenefits are estimated at 30% of salaries and 3% annual increase
bPharmacy department facility costs have not been included.
Benefits
• People
– Enhances image of work environment of choice for Department of Pharmacy
– Improved pharmacist recruitment
– Renewable supply of clinically trained pharmacists in case of personnel turnover or
service expansion
• Performance
– Enhanced clinical pharmacy services
– Enhanced operational and financial performance
– Increased cost savings/cost avoidance realized by Hospital C
– Expansion of clinical pharmacy services into new patient care areas
– Increased clinical pharmacy interventions
– Increased pharmacy-initiated patient care services
– Enhanced pharmaceutical use
– Enhanced patient care and safety
– Contribution to inpatient drug distribution
– Increased participation in community outreach programs
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• Physician Relations
– Establish and foster new partnerships with medical staff
– Expanded multidisciplinary opportunities and services
– Enhanced clinical quality and safety of patient care
• Strategic Growth
– Expanded clinical services within Hospital C
– Become only community hospital site for residency training
– Increase institution’s association with colleges of pharmacy
– Enhance image as the region’s leading provider of pharmaceutical care
– Become one of only three network institutions with pharmacy residency programs
– Enhance image as a leading institution within health network
Potential Obstacles
• Office space in the pharmacy
• Need to develop preceptor skills of clinical staff pharmacists
Timeline
August
• ASHP MCM recruitment fee
• ASHP National Residency Preceptors Conference
October
• Pharmacy practice residency approval
• Residency Policy and Procedure Manual development
• Begin position advertising and recruitment.
December
• Recruitment at ASHP MCM
• Follow-up correspondence sent to prospective applicants after ASHP MCM
January
• Accept applications from prospective candidates.
February
• Interview prospective candidates on-site.
March
• Offer resident positions.
July
• Residency begins—Year One
• Submit application for accreditation to ASHP.
• Submit program to Resident Matching Program.
December
• Recruitment at ASHP MCM—Year Two
• Follow-up correspondence sent to prospective applicants after ASHP MCM—Year Two
January
• Accept applications from prospective candidates—Year Two
February
• Interview prospective candidates on-site—Year Two
March
• Offer resident positions through Resident Matching Program—Year Two
• Resident Matching Program results—Year Two
• ASHP on-site accreditation process
May
• ASHP accreditation approval—retroactive for all of Year One
• Submission to Medicare for GME pass-through reimbursement—retroactive for all of Year
One
• Establish Medicare GME pass-through reimbursement for Year Two+
July
• Residency begins—Year Two
Conclusion
Pharmacy residency training is directly aligned with the strategic goals, mission, and vision
of Hospital C. Such training would provide a unique opportunity for Hospital C to improve
patient care delivered by the Department of Pharmacy as well as to enhance the health care
provided to the communities Hospital C serves. A PGY-1 pharmacy residency program would
allow Hospital C to continue as a leader within the health network and advance its image as the
region’s leading provider of pharmaceutical care. This program should be considered a critical
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part of Hospital C’s strategic plan for pharmacist recruitment and retention, reduction of
patient care costs, enhanced patient care, and strategic pharmacy growth.
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